| KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study BD Shah, A Ghobadi, OO Oluwole, AC Logan, N Boissel, RD Cassaday, ... The Lancet 398 (10299), 491-502, 2021 | 548 | 2021 |
| Ibrutinib for chronic graft-versus-host disease after failure of prior therapy D Miklos, CS Cutler, M Arora, EK Waller, M Jagasia, I Pusic, ME Flowers, ... Blood, The Journal of the American Society of Hematology 130 (21), 2243-2250, 2017 | 484 | 2017 |
| Clonal selection with RAS pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia CM McMahon, T Ferng, J Canaani, ES Wang, JJD Morrissette, ... Cancer discovery 9 (8), 1050-1063, 2019 | 392 | 2019 |
| Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications V Yank, CV Tuohy, AC Logan, DM Bravata, K Staudenmayer, R Eisenhut, ... Annals of internal medicine 154 (8), 529-540, 2011 | 294 | 2011 |
| High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment AC Logan, H Gao, C Wang, B Sahaf, CD Jones, EL Marshall, I Buño, ... Proceedings of the National Academy of Sciences 108 (52), 21194-21199, 2011 | 246 | 2011 |
| Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study C Cutler, SJ Lee, S Arai, M Rotta, B Zoghi, A Lazaryan, A Ramakrishnan, ... Blood, The Journal of the American Society of Hematology 138 (22), 2278-2289, 2021 | 188 | 2021 |
| Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology PA Brown, B Shah, A Advani, P Aoun, MW Boyer, PW Burke, ... Journal of the National Comprehensive Cancer Network 19 (9), 1079-1109, 2021 | 171 | 2021 |
| Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia AC Logan, B Zhang, B Narasimhan, V Carlton, J Zheng, M Moorhead, ... Leukemia 27 (8), 1659-1665, 2013 | 169 | 2013 |
| Factors influencing the titer and infectivity of lentiviral vectors AC Logan, SJ Nightingale, DL Haas, GJ Cho, KA Pepper, DB Kohn Human gene therapy 15 (10), 976-988, 2004 | 164 | 2004 |
| Off-label use of recombinant factor VIIa in US hospitals: analysis of hospital records AC Logan, V Yank, RS Stafford Annals of Internal Medicine 154 (8), 516-522, 2011 | 160 | 2011 |
| Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse … AC Logan, N Vashi, M Faham, V Carlton, K Kong, I Buño, J Zheng, ... Biology of Blood and Marrow Transplantation 20 (9), 1307-1313, 2014 | 155 | 2014 |
| Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia C Gawad, F Pepin, VEH Carlton, M Klinger, AC Logan, DB Miklos, ... Blood, The Journal of the American Society of Hematology 120 (22), 4407-4417, 2012 | 145 | 2012 |
| KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results BD Shah, MR Bishop, OO Oluwole, AC Logan, MR Baer, WB Donnellan, ... Blood, The Journal of the American Society of Hematology 138 (1), 11-22, 2021 | 143 | 2021 |
| Advances in lentiviral vector design for gene-modification of hematopoietic stem cells AC Logan, C Lutzko, DB Kohn Current opinion in biotechnology 13 (5), 429-436, 2002 | 130 | 2002 |
| Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: a consensus of North American experts NJ Short, E Jabbour, M Albitar, M de Lima, L Gore, J Jorgensen, ... American journal of hematology 94 (2), 257-265, 2019 | 124 | 2019 |
| Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration AC Logan, DL Haas, T Kafri, DB Kohn Journal of virology 78 (16), 8421-8436, 2004 | 121 | 2004 |
| The impact of host starvation on parasite development and population dynamics in an intestinal trypanosome parasite of bumble bees A Logan, MX Ruiz-González, MJF Brown Parasitology 130 (6), 637-642, 2005 | 107 | 2005 |
| Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia B Kharabi Masouleh, H Geng, C Hurtz, LN Chan, AC Logan, MS Chang, ... Proceedings of the National Academy of Sciences 111 (21), E2219-E2228, 2014 | 106 | 2014 |
| Ibrutinib for chronic graft-versus-host disease after failure of prior therapy: 1-year update of a phase 1b/2 study EK Waller, D Miklos, C Cutler, M Arora, MH Jagasia, I Pusic, MED Flowers, ... Biology of Blood and Marrow Transplantation 25 (10), 2002-2007, 2019 | 104 | 2019 |
| Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells DW Sherbenou, BT Aftab, Y Su, CR Behrens, A Wiita, AC Logan, ... The Journal of clinical investigation 126 (12), 4640-4653, 2016 | 102 | 2016 |
